

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.07889573 |
| 2 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.88143714 |
| 3 | ATP hydrolysis coupled proton transport (GO:0015991) | 4.88143714 |
| 4 | neuron cell-cell adhesion (GO:0007158) | 4.74753334 |
| 5 | transferrin transport (GO:0033572) | 4.73653036 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.45491755 |
| 7 | trivalent inorganic cation transport (GO:0072512) | 4.42871256 |
| 8 | ferric iron transport (GO:0015682) | 4.42871256 |
| 9 | neuronal action potential propagation (GO:0019227) | 4.40790255 |
| 10 | presynaptic membrane assembly (GO:0097105) | 4.38974635 |
| 11 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.34168740 |
| 12 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.26152767 |
| 13 | vocalization behavior (GO:0071625) | 4.18782056 |
| 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.10747819 |
| 15 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.09534826 |
| 16 | glutamate secretion (GO:0014047) | 4.06592409 |
| 17 | presynaptic membrane organization (GO:0097090) | 4.06159668 |
| 18 | oligosaccharide catabolic process (GO:0009313) | 4.05227418 |
| 19 | phagosome maturation (GO:0090382) | 4.01983086 |
| 20 | regulation of synaptic vesicle transport (GO:1902803) | 3.89421271 |
| 21 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.80862619 |
| 22 | neuron-neuron synaptic transmission (GO:0007270) | 3.79504747 |
| 23 | glycosphingolipid catabolic process (GO:0046479) | 3.70897735 |
| 24 | protein localization to synapse (GO:0035418) | 3.68843212 |
| 25 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.68806685 |
| 26 | neurotransmitter secretion (GO:0007269) | 3.65600362 |
| 27 | amino sugar catabolic process (GO:0046348) | 3.63922969 |
| 28 | keratan sulfate catabolic process (GO:0042340) | 3.61139034 |
| 29 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.54806119 |
| 30 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.52220947 |
| 31 | postsynaptic membrane organization (GO:0001941) | 3.47049415 |
| 32 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.46281179 |
| 33 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.42664351 |
| 34 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.42053488 |
| 35 | long-term synaptic potentiation (GO:0060291) | 3.40164879 |
| 36 | negative regulation of neurotransmitter transport (GO:0051589) | 3.39781714 |
| 37 | synaptic transmission, glutamatergic (GO:0035249) | 3.38520021 |
| 38 | glycolipid catabolic process (GO:0019377) | 3.33703524 |
| 39 | response to histamine (GO:0034776) | 3.33547502 |
| 40 | glutamate receptor signaling pathway (GO:0007215) | 3.29926269 |
| 41 | synaptic vesicle maturation (GO:0016188) | 3.28778385 |
| 42 | detection of calcium ion (GO:0005513) | 3.27649657 |
| 43 | startle response (GO:0001964) | 3.24775059 |
| 44 | membrane lipid catabolic process (GO:0046466) | 3.23564211 |
| 45 | sphingolipid catabolic process (GO:0030149) | 3.20953799 |
| 46 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.20106410 |
| 47 | neurotransmitter transport (GO:0006836) | 3.19762759 |
| 48 | glucosamine-containing compound catabolic process (GO:1901072) | 3.14195438 |
| 49 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.13991080 |
| 50 | ceramide catabolic process (GO:0046514) | 3.13385615 |
| 51 | regulation of mononuclear cell migration (GO:0071675) | 3.13005671 |
| 52 | eosinophil chemotaxis (GO:0048245) | 3.04112126 |
| 53 | regulation of glutamate secretion (GO:0014048) | 3.03112714 |
| 54 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.02110196 |
| 55 | establishment of synaptic vesicle localization (GO:0097480) | 3.01799616 |
| 56 | synaptic vesicle transport (GO:0048489) | 3.01799616 |
| 57 | regulation of vesicle fusion (GO:0031338) | 3.01009793 |
| 58 | gamma-aminobutyric acid transport (GO:0015812) | 3.00307198 |
| 59 | neuron recognition (GO:0008038) | 2.97662966 |
| 60 | intracellular pH reduction (GO:0051452) | 2.97606306 |
| 61 | signal peptide processing (GO:0006465) | 2.93605647 |
| 62 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.91958867 |
| 63 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.91791372 |
| 64 | regulation of neurotransmitter levels (GO:0001505) | 2.91727777 |
| 65 | positive regulation of synapse assembly (GO:0051965) | 2.91606718 |
| 66 | proline transport (GO:0015824) | 2.91038022 |
| 67 | regulation of neurotransmitter secretion (GO:0046928) | 2.90730292 |
| 68 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.90207892 |
| 69 | locomotory exploration behavior (GO:0035641) | 2.89087348 |
| 70 | synaptic transmission, dopaminergic (GO:0001963) | 2.87672846 |
| 71 | regulation of catecholamine metabolic process (GO:0042069) | 2.85977141 |
| 72 | regulation of dopamine metabolic process (GO:0042053) | 2.85977141 |
| 73 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.85129019 |
| 74 | behavioral response to cocaine (GO:0048148) | 2.85114492 |
| 75 | synaptic vesicle endocytosis (GO:0048488) | 2.84629279 |
| 76 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.83631118 |
| 77 | neuromuscular process controlling posture (GO:0050884) | 2.83559053 |
| 78 | pH reduction (GO:0045851) | 2.82942144 |
| 79 | regulation of postsynaptic membrane potential (GO:0060078) | 2.80167660 |
| 80 | ganglioside metabolic process (GO:0001573) | 2.80132143 |
| 81 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.79928504 |
| 82 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.79172236 |
| 83 | neurotransmitter uptake (GO:0001504) | 2.78784217 |
| 84 | transmission of nerve impulse (GO:0019226) | 2.78554401 |
| 85 | positive regulation of neurotransmitter transport (GO:0051590) | 2.78227469 |
| 86 | regulation of neurotransmitter transport (GO:0051588) | 2.78070182 |
| 87 | response to cocaine (GO:0042220) | 2.78055919 |
| 88 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.78001585 |
| 89 | protein localization to cilium (GO:0061512) | 2.77777050 |
| 90 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.77399644 |
| 91 | positive regulation of membrane potential (GO:0045838) | 2.76068953 |
| 92 | iron ion transport (GO:0006826) | 2.75148958 |
| 93 | mechanosensory behavior (GO:0007638) | 2.74394660 |
| 94 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.74278900 |
| 95 | eosinophil migration (GO:0072677) | 2.73847413 |
| 96 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.73255772 |
| 97 | establishment of vesicle localization (GO:0051650) | 2.72732304 |
| 98 | dopamine biosynthetic process (GO:0042416) | 2.71996760 |
| 99 | positive regulation of calcium ion import (GO:0090280) | 2.71497662 |
| 100 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.70908026 |
| 101 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.70908026 |
| 102 | synaptic transmission (GO:0007268) | 2.70806532 |
| 103 | regulation of exocytosis (GO:0017157) | 2.70578983 |
| 104 | chaperone-mediated protein transport (GO:0072321) | 2.70215668 |
| 105 | negative regulation of amine transport (GO:0051953) | 2.68114851 |
| 106 | lytic vacuole organization (GO:0080171) | 2.67771669 |
| 107 | lysosome organization (GO:0007040) | 2.67771669 |
| 108 | exploration behavior (GO:0035640) | 2.67653107 |
| 109 | regulation of synaptic plasticity (GO:0048167) | 2.67297375 |
| 110 | cerebellar granule cell differentiation (GO:0021707) | 2.66317477 |
| 111 | dopamine transport (GO:0015872) | 2.66226114 |
| 112 | positive regulation of exocytosis (GO:0045921) | 2.66132637 |
| 113 | synapse assembly (GO:0007416) | 2.64655644 |
| 114 | negative regulation of synaptic transmission (GO:0050805) | 2.64519850 |
| 115 | female mating behavior (GO:0060180) | 2.63615579 |
| 116 | respiratory electron transport chain (GO:0022904) | 2.63074565 |
| 117 | protein neddylation (GO:0045116) | 2.62207642 |
| 118 | positive regulation of synaptic transmission (GO:0050806) | 2.60583299 |
| 119 | ER overload response (GO:0006983) | 2.60192901 |
| 120 | neutrophil activation involved in immune response (GO:0002283) | 2.55661795 |
| 121 | response to lipoprotein particle (GO:0055094) | 2.54653849 |
| 122 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.54030267 |
| 123 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.53347894 |
| 124 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.52811216 |
| 125 | cellular iron ion homeostasis (GO:0006879) | 2.49227852 |
| 126 | regulation of beta-amyloid formation (GO:1902003) | 2.47998870 |
| 127 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.46282618 |
| 128 | sphingosine metabolic process (GO:0006670) | 2.44659189 |
| 129 | macroautophagy (GO:0016236) | 2.44541363 |
| 130 | glycosphingolipid metabolic process (GO:0006687) | 2.43818654 |
| 131 | glycerophospholipid catabolic process (GO:0046475) | 2.43393327 |
| 132 | regulation of fever generation (GO:0031620) | 2.38883630 |
| 133 | chondroitin sulfate catabolic process (GO:0030207) | 2.38663820 |
| 134 | positive regulation of actin filament depolymerization (GO:0030836) | 2.35995782 |
| 135 | N-acetylneuraminate metabolic process (GO:0006054) | 2.32716419 |
| 136 | alanine transport (GO:0032328) | 2.30852286 |
| 137 | cellular transition metal ion homeostasis (GO:0046916) | 2.30318632 |
| 138 | positive regulation of heat generation (GO:0031652) | 2.29938453 |
| 139 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.29448884 |
| 140 | platelet dense granule organization (GO:0060155) | 2.24891629 |
| 141 | negative regulation of interleukin-12 production (GO:0032695) | 2.24167629 |
| 142 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.20215257 |
| 143 | inositol phosphate catabolic process (GO:0071545) | 2.20028128 |
| 144 | magnesium ion transport (GO:0015693) | 2.18762951 |
| 145 | diol metabolic process (GO:0034311) | 2.17472382 |
| 146 | prostate gland growth (GO:0060736) | 2.17457177 |
| 147 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.16748335 |
| 148 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.16367199 |
| 149 | xenobiotic catabolic process (GO:0042178) | 2.16312569 |
| 150 | Golgi transport vesicle coating (GO:0048200) | 2.10502619 |
| 151 | COPI coating of Golgi vesicle (GO:0048205) | 2.10502619 |
| 152 | inositol phosphate-mediated signaling (GO:0048016) | 2.09899808 |
| 153 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.07309627 |
| 154 | inositol phosphate dephosphorylation (GO:0046855) | 2.07309627 |
| 155 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.07155463 |
| 156 | insulin secretion (GO:0030073) | 2.06224599 |
| 157 | response to dietary excess (GO:0002021) | 2.05869511 |
| 158 | transition metal ion transport (GO:0000041) | 2.05804965 |
| 159 | nitric oxide biosynthetic process (GO:0006809) | 2.03720423 |
| 160 | * peptide hormone processing (GO:0016486) | 2.03587134 |
| 161 | amyloid precursor protein catabolic process (GO:0042987) | 2.03410172 |
| 162 | response to hydroperoxide (GO:0033194) | 2.03126394 |
| 163 | positive regulation of osteoclast differentiation (GO:0045672) | 2.02948736 |
| 164 | response to thyroid hormone (GO:0097066) | 2.02738608 |
| 165 | cell adhesion mediated by integrin (GO:0033627) | 2.02480092 |
| 166 | regulation of monocyte chemotaxis (GO:0090025) | 2.02417917 |
| 167 | vasodilation (GO:0042311) | 2.02335100 |
| 168 | regulation of autophagic vacuole assembly (GO:2000785) | 2.02157672 |
| 169 | regulation of heat generation (GO:0031650) | 2.01652062 |
| 170 | regulation of intracellular pH (GO:0051453) | 1.99508040 |
| 171 | sphingoid metabolic process (GO:0046519) | 1.99285107 |
| 172 | sphingolipid metabolic process (GO:0006665) | 1.99269100 |
| 173 | glycolipid metabolic process (GO:0006664) | 1.98469267 |
| 174 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 1.98170062 |
| 175 | protein localization to endosome (GO:0036010) | 1.97903809 |
| 176 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 1.96568839 |
| 177 | glycosphingolipid biosynthetic process (GO:0006688) | 1.96374619 |
| 178 | zinc ion transport (GO:0006829) | 1.96310508 |
| 179 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 1.96006997 |
| 180 | liposaccharide metabolic process (GO:1903509) | 1.95771029 |
| 181 | cellular copper ion homeostasis (GO:0006878) | 1.95463033 |
| 182 | vitamin D metabolic process (GO:0042359) | 1.94547829 |
| 183 | positive regulation of protein autophosphorylation (GO:0031954) | 1.94462136 |
| 184 | positive regulation of leukocyte degranulation (GO:0043302) | 1.93518429 |
| 185 | regulation of vacuole organization (GO:0044088) | 1.92754335 |
| 186 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 1.92655616 |
| 187 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 1.91986778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.76224386 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.59123202 |
| 3 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.35815522 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.00416460 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.90470592 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.71462976 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.63921292 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.54560723 |
| 9 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.49007211 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.48847714 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.48644916 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.41929931 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.37605752 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.34650801 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.25371923 |
| 16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.20922218 |
| 17 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.20235883 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.18767994 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.17406635 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.11816117 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.10405284 |
| 22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.08722717 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.08704071 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.05286115 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.05226485 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.01897738 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.01753810 |
| 28 | * P300_19829295_ChIP-Seq_ESCs_Human | 2.00203132 |
| 29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.99299540 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.97530069 |
| 31 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.97530069 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.94930168 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.94223494 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.91484957 |
| 35 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.89311900 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.80638270 |
| 37 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.80195465 |
| 38 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.77646776 |
| 39 | FUS_26573619_Chip-Seq_HEK293_Human | 1.74165396 |
| 40 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.71325512 |
| 41 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.71061597 |
| 42 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.69686681 |
| 43 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.65008481 |
| 44 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.63812940 |
| 45 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.63348761 |
| 46 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60645487 |
| 47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.60575028 |
| 48 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.60522319 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.55667711 |
| 50 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.54491429 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.53229144 |
| 52 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.52457790 |
| 53 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52246170 |
| 54 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51740558 |
| 55 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.48546945 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.46208393 |
| 57 | AR_25329375_ChIP-Seq_VCAP_Human | 1.44531432 |
| 58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44131126 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.43278223 |
| 60 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.39006228 |
| 61 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.38177714 |
| 62 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.36749482 |
| 63 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.34692971 |
| 64 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34584318 |
| 65 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.34273920 |
| 66 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.32211444 |
| 67 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32161122 |
| 68 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.31187064 |
| 69 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30256976 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30146734 |
| 71 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.29225243 |
| 72 | CJUN_26792858_Chip-Seq_BT549_Human | 1.29164631 |
| 73 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.29042699 |
| 74 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.28541345 |
| 75 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27944863 |
| 76 | JUN_21703547_ChIP-Seq_K562_Human | 1.26769594 |
| 77 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25896175 |
| 78 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.25285150 |
| 79 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24950590 |
| 80 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.24557281 |
| 81 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24332308 |
| 82 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.24262267 |
| 83 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22400094 |
| 84 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21331081 |
| 85 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.21143106 |
| 86 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.19610003 |
| 87 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.18725242 |
| 88 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.18681251 |
| 89 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18129988 |
| 90 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.17879047 |
| 91 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17702273 |
| 92 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16501172 |
| 93 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.16375091 |
| 94 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.16140131 |
| 95 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.15499323 |
| 96 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15443143 |
| 97 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.13470266 |
| 98 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12995550 |
| 99 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12055426 |
| 100 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11285964 |
| 101 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10305813 |
| 102 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09591879 |
| 103 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.07399263 |
| 104 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.06724500 |
| 105 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06629640 |
| 106 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.06424287 |
| 107 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06069250 |
| 108 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.05965553 |
| 109 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.05965553 |
| 110 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.05658418 |
| 111 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05160523 |
| 112 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05018592 |
| 113 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04896786 |
| 114 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04896786 |
| 115 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.04134773 |
| 116 | KDM2B_26808549_Chip-Seq_REH_Human | 1.03859904 |
| 117 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02955928 |
| 118 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02877441 |
| 119 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.02753073 |
| 120 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02152449 |
| 121 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01829051 |
| 122 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01825867 |
| 123 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01033598 |
| 124 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.00740751 |
| 125 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.00518724 |
| 126 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00439124 |
| 127 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00032690 |
| 128 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.99676733 |
| 129 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.99526556 |
| 130 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99421087 |
| 131 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.98973834 |
| 132 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.97908593 |
| 133 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97783827 |
| 134 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.97183030 |
| 135 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96756922 |
| 136 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.96568714 |
| 137 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96122396 |
| 138 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95690117 |
| 139 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.95354653 |
| 140 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.95354653 |
| 141 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.94443429 |
| 142 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.94103340 |
| 143 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.93933089 |
| 144 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.93804030 |
| 145 | EWS_26573619_Chip-Seq_HEK293_Human | 0.93574434 |
| 146 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.93545495 |
| 147 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93501440 |
| 148 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.93443099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.93432990 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.92409729 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.44295149 |
| 4 | MP0009046_muscle_twitch | 3.29669084 |
| 5 | MP0002064_seizures | 3.20403954 |
| 6 | MP0009745_abnormal_behavioral_response | 3.17436469 |
| 7 | MP0006082_CNS_inflammation | 3.10179752 |
| 8 | MP0004270_analgesia | 3.01181180 |
| 9 | MP0006054_spinal_hemorrhage | 3.00094753 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.82194897 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.78591677 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.69091197 |
| 13 | MP0002736_abnormal_nociception_after | 2.66539649 |
| 14 | MP0002272_abnormal_nervous_system | 2.62291080 |
| 15 | MP0009840_abnormal_foam_cell | 2.58176617 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.55643649 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.51038320 |
| 18 | MP0001529_abnormal_vocalization | 2.42959659 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.41952250 |
| 20 | MP0003724_increased_susceptibility_to | 2.36478112 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 2.27273506 |
| 22 | MP0010386_abnormal_urinary_bladder | 2.25337045 |
| 23 | MP0003183_abnormal_peptide_metabolism | 2.24180077 |
| 24 | MP0001486_abnormal_startle_reflex | 2.20314557 |
| 25 | MP0006276_abnormal_autonomic_nervous | 2.18710472 |
| 26 | MP0003075_altered_response_to | 2.18406428 |
| 27 | MP0001440_abnormal_grooming_behavior | 2.16680049 |
| 28 | MP0002254_reproductive_system_inflammat | 2.15318991 |
| 29 | MP0005646_abnormal_pituitary_gland | 2.14722854 |
| 30 | MP0001970_abnormal_pain_threshold | 2.11311010 |
| 31 | MP0002733_abnormal_thermal_nociception | 2.07734759 |
| 32 | MP0002822_catalepsy | 2.06301643 |
| 33 | MP0003303_peritoneal_inflammation | 2.03964628 |
| 34 | MP0001905_abnormal_dopamine_level | 2.03920280 |
| 35 | MP0002067_abnormal_sensory_capabilities | 2.00860154 |
| 36 | MP0002139_abnormal_hepatobiliary_system | 1.96103741 |
| 37 | MP0000343_altered_response_to | 1.87584266 |
| 38 | MP0004043_abnormal_pH_regulation | 1.82822515 |
| 39 | MP0003329_amyloid_beta_deposits | 1.82645944 |
| 40 | MP0002837_dystrophic_cardiac_calcinosis | 1.80830333 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.79955929 |
| 42 | MP0002876_abnormal_thyroid_physiology | 1.77069646 |
| 43 | MP0004142_abnormal_muscle_tone | 1.75480669 |
| 44 | MP0005423_abnormal_somatic_nervous | 1.74018287 |
| 45 | MP0001984_abnormal_olfaction | 1.73913136 |
| 46 | MP0004924_abnormal_behavior | 1.73616548 |
| 47 | MP0005386_behavior/neurological_phenoty | 1.73616548 |
| 48 | MP0002909_abnormal_adrenal_gland | 1.72571380 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.72277283 |
| 50 | MP0001542_abnormal_bone_strength | 1.71410104 |
| 51 | MP0001188_hyperpigmentation | 1.65997604 |
| 52 | MP0002148_abnormal_hypersensitivity_rea | 1.65186753 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.61834337 |
| 54 | MP0003879_abnormal_hair_cell | 1.60769039 |
| 55 | MP0010234_abnormal_vibrissa_follicle | 1.60277749 |
| 56 | MP0003122_maternal_imprinting | 1.59055207 |
| 57 | MP0009785_altered_susceptibility_to | 1.58707877 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.57581053 |
| 59 | MP0005645_abnormal_hypothalamus_physiol | 1.57101934 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.52876237 |
| 61 | MP0002295_abnormal_pulmonary_circulatio | 1.50779609 |
| 62 | MP0008438_abnormal_cutaneous_collagen | 1.50555115 |
| 63 | MP0002557_abnormal_social/conspecific_i | 1.48425872 |
| 64 | MP0002419_abnormal_innate_immunity | 1.43977803 |
| 65 | MP0003300_gastrointestinal_ulcer | 1.43905076 |
| 66 | MP0005379_endocrine/exocrine_gland_phen | 1.42481724 |
| 67 | MP0002184_abnormal_innervation | 1.41559548 |
| 68 | MP0008569_lethality_at_weaning | 1.38530897 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.37893732 |
| 70 | MP0001502_abnormal_circadian_rhythm | 1.36463113 |
| 71 | MP0005171_absent_coat_pigmentation | 1.34078086 |
| 72 | MP0002066_abnormal_motor_capabilities/c | 1.30172043 |
| 73 | MP0003011_delayed_dark_adaptation | 1.29221616 |
| 74 | MP0003633_abnormal_nervous_system | 1.24540143 |
| 75 | MP0004811_abnormal_neuron_physiology | 1.22549546 |
| 76 | MP0001756_abnormal_urination | 1.21199202 |
| 77 | MP0000955_abnormal_spinal_cord | 1.19469220 |
| 78 | MP0002229_neurodegeneration | 1.19318664 |
| 79 | MP0000778_abnormal_nervous_system | 1.19290295 |
| 80 | MP0003172_abnormal_lysosome_physiology | 1.18637967 |
| 81 | MP0002882_abnormal_neuron_morphology | 1.15728074 |
| 82 | MP0004019_abnormal_vitamin_homeostasis | 1.15005109 |
| 83 | MP0004510_myositis | 1.14838363 |
| 84 | MP0005166_decreased_susceptibility_to | 1.14684762 |
| 85 | MP0003436_decreased_susceptibility_to | 1.14021872 |
| 86 | MP0005535_abnormal_body_temperature | 1.12189540 |
| 87 | MP0009764_decreased_sensitivity_to | 1.12022599 |
| 88 | MP0005165_increased_susceptibility_to | 1.11707343 |
| 89 | MP0003787_abnormal_imprinting | 1.11384682 |
| 90 | MP0000920_abnormal_myelination | 1.09616104 |
| 91 | MP0000604_amyloidosis | 1.09237633 |
| 92 | MP0002638_abnormal_pupillary_reflex | 1.08256657 |
| 93 | MP0003631_nervous_system_phenotype | 1.07172847 |
| 94 | MP0002998_abnormal_bone_remodeling | 1.06738094 |
| 95 | MP0003634_abnormal_glial_cell | 1.05580656 |
| 96 | MP0005464_abnormal_platelet_physiology | 1.04549580 |
| 97 | MP0005058_abnormal_lysosome_morphology | 1.04351378 |
| 98 | MP0001664_abnormal_digestion | 1.03424492 |
| 99 | MP0003195_calcinosis | 1.03356537 |
| 100 | MP0003279_aneurysm | 1.02307707 |
| 101 | MP0005551_abnormal_eye_electrophysiolog | 1.01710769 |
| 102 | MP0004742_abnormal_vestibular_system | 1.01524397 |
| 103 | MP0001963_abnormal_hearing_physiology | 0.99019541 |
| 104 | MP0005000_abnormal_immune_tolerance | 0.98583358 |
| 105 | MP0010329_abnormal_lipoprotein_level | 0.98378600 |
| 106 | MP0005671_abnormal_response_to | 0.97635611 |
| 107 | MP0005164_abnormal_response_to | 0.97150770 |
| 108 | MP0002163_abnormal_gland_morphology | 0.96897678 |
| 109 | MP0005365_abnormal_bile_salt | 0.96857881 |
| 110 | MP0003690_abnormal_glial_cell | 0.96274497 |
| 111 | MP0004883_abnormal_blood_vessel | 0.94204668 |
| 112 | MP0001845_abnormal_inflammatory_respons | 0.94180972 |
| 113 | MP0002693_abnormal_pancreas_physiology | 0.93659522 |
| 114 | MP0003186_abnormal_redox_activity | 0.93497472 |
| 115 | MP0002090_abnormal_vision | 0.93084382 |
| 116 | MP0008260_abnormal_autophagy | 0.92982437 |
| 117 | MP0008469_abnormal_protein_level | 0.92660183 |
| 118 | MP0004858_abnormal_nervous_system | 0.92050017 |
| 119 | MP0005248_abnormal_Harderian_gland | 0.90117916 |
| 120 | MP0008872_abnormal_physiological_respon | 0.87678420 |
| 121 | MP0005387_immune_system_phenotype | 0.85945818 |
| 122 | MP0001790_abnormal_immune_system | 0.85945818 |
| 123 | MP0003795_abnormal_bone_structure | 0.85616891 |
| 124 | MP0002069_abnormal_eating/drinking_beha | 0.85394717 |
| 125 | MP0001853_heart_inflammation | 0.85227585 |
| 126 | MP0000631_abnormal_neuroendocrine_gland | 0.83890675 |
| 127 | MP0002896_abnormal_bone_mineralization | 0.83716048 |
| 128 | MP0004885_abnormal_endolymph | 0.83349166 |
| 129 | MP0001835_abnormal_antigen_presentation | 0.83052165 |
| 130 | MP0005257_abnormal_intraocular_pressure | 0.82956459 |
| 131 | MP0001958_emphysema | 0.82672711 |
| 132 | MP0005367_renal/urinary_system_phenotyp | 0.81150068 |
| 133 | MP0000516_abnormal_urinary_system | 0.81150068 |
| 134 | MP0005025_abnormal_response_to | 0.80348866 |
| 135 | MP0003656_abnormal_erythrocyte_physiolo | 0.79573045 |
| 136 | MP0003632_abnormal_nervous_system | 0.78270466 |
| 137 | MP0005310_abnormal_salivary_gland | 0.76160946 |
| 138 | MP0000465_gastrointestinal_hemorrhage | 0.74823368 |
| 139 | MP0001765_abnormal_ion_homeostasis | 0.74276566 |
| 140 | MP0006072_abnormal_retinal_apoptosis | 0.69332302 |
| 141 | MP0002152_abnormal_brain_morphology | 0.69251328 |
| 142 | MP0008874_decreased_physiological_sensi | 0.68480952 |
| 143 | MP0000681_abnormal_thyroid_gland | 0.68463473 |
| 144 | MP0001485_abnormal_pinna_reflex | 0.65973112 |
| 145 | MP0008004_abnormal_stomach_pH | 0.62673839 |
| 146 | MP0001177_atelectasis | 0.60448349 |
| 147 | MP0002752_abnormal_somatic_nervous | 0.59464100 |
| 148 | MP0004085_abnormal_heartbeat | 0.57805712 |
| 149 | MP0000230_abnormal_systemic_arterial | 0.55802593 |
| 150 | MP0002078_abnormal_glucose_homeostasis | 0.54493366 |
| 151 | MP0005253_abnormal_eye_physiology | 0.54004757 |
| 152 | MP0000026_abnormal_inner_ear | 0.53991403 |
| 153 | MP0000538_abnormal_urinary_bladder | 0.52447675 |
| 154 | MP0006036_abnormal_mitochondrial_physio | 0.51033499 |
| 155 | MP0005394_taste/olfaction_phenotype | 0.50471115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.77725364 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 5.83876806 |
| 3 | Atonic seizures (HP:0010819) | 5.31929548 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.73337629 |
| 5 | Visual hallucinations (HP:0002367) | 4.37688627 |
| 6 | Febrile seizures (HP:0002373) | 4.31565220 |
| 7 | Focal seizures (HP:0007359) | 4.28945947 |
| 8 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.15157248 |
| 9 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.15157248 |
| 10 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.15157248 |
| 11 | Absence seizures (HP:0002121) | 4.08320357 |
| 12 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.01246314 |
| 13 | Mucopolysacchariduria (HP:0008155) | 4.01246314 |
| 14 | Pheochromocytoma (HP:0002666) | 4.00478763 |
| 15 | Acute necrotizing encephalopathy (HP:0006965) | 3.93998994 |
| 16 | Neuroendocrine neoplasm (HP:0100634) | 3.87970241 |
| 17 | Loss of speech (HP:0002371) | 3.87613850 |
| 18 | Hyperventilation (HP:0002883) | 3.87247400 |
| 19 | Dialeptic seizures (HP:0011146) | 3.87176196 |
| 20 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.79361854 |
| 21 | Myokymia (HP:0002411) | 3.78273888 |
| 22 | Disinhibition (HP:0000734) | 3.52377739 |
| 23 | Progressive macrocephaly (HP:0004481) | 3.42164118 |
| 24 | Progressive neurologic deterioration (HP:0002344) | 3.36539852 |
| 25 | Mitochondrial inheritance (HP:0001427) | 3.26880615 |
| 26 | Abnormal hair whorl (HP:0010721) | 3.19519220 |
| 27 | Abnormality of macrophages (HP:0004311) | 3.19487311 |
| 28 | Limb dystonia (HP:0002451) | 3.04140625 |
| 29 | Hematochezia (HP:0002573) | 3.00393816 |
| 30 | Acute encephalopathy (HP:0006846) | 2.99774902 |
| 31 | Progressive cerebellar ataxia (HP:0002073) | 2.99522879 |
| 32 | Hypothermia (HP:0002045) | 2.94177761 |
| 33 | * Generalized tonic-clonic seizures (HP:0002069) | 2.92279960 |
| 34 | Gait imbalance (HP:0002141) | 2.91209647 |
| 35 | Increased CSF protein (HP:0002922) | 2.86803804 |
| 36 | Polyphagia (HP:0002591) | 2.85237974 |
| 37 | Systemic lupus erythematosus (HP:0002725) | 2.83593068 |
| 38 | Medial flaring of the eyebrow (HP:0010747) | 2.83274127 |
| 39 | Nuclear cataract (HP:0100018) | 2.82221498 |
| 40 | Epileptiform EEG discharges (HP:0011182) | 2.73783591 |
| 41 | Increased CSF lactate (HP:0002490) | 2.73348088 |
| 42 | Failure to thrive in infancy (HP:0001531) | 2.72844125 |
| 43 | Congenital primary aphakia (HP:0007707) | 2.71528392 |
| 44 | Neurofibrillary tangles (HP:0002185) | 2.70413485 |
| 45 | Cerebral inclusion bodies (HP:0100314) | 2.64658061 |
| 46 | Supranuclear gaze palsy (HP:0000605) | 2.63380174 |
| 47 | Diplopia (HP:0000651) | 2.62036836 |
| 48 | Abnormality of binocular vision (HP:0011514) | 2.62036836 |
| 49 | Abnormal eating behavior (HP:0100738) | 2.61907167 |
| 50 | Nephrogenic diabetes insipidus (HP:0009806) | 2.60472908 |
| 51 | Apathy (HP:0000741) | 2.59915676 |
| 52 | Diminished motivation (HP:0000745) | 2.58381670 |
| 53 | Poor suck (HP:0002033) | 2.54912364 |
| 54 | EEG with generalized epileptiform discharges (HP:0011198) | 2.54318583 |
| 55 | Hepatocellular necrosis (HP:0001404) | 2.52919433 |
| 56 | Progressive inability to walk (HP:0002505) | 2.51832266 |
| 57 | Broad-based gait (HP:0002136) | 2.51113056 |
| 58 | Truncal ataxia (HP:0002078) | 2.45940745 |
| 59 | Anxiety (HP:0000739) | 2.44598870 |
| 60 | Hypsarrhythmia (HP:0002521) | 2.37285902 |
| 61 | Tongue fasciculations (HP:0001308) | 2.34216305 |
| 62 | Stomatitis (HP:0010280) | 2.32542297 |
| 63 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.29203753 |
| 64 | Intention tremor (HP:0002080) | 2.24679098 |
| 65 | Akinesia (HP:0002304) | 2.23078840 |
| 66 | Gaze-evoked nystagmus (HP:0000640) | 2.21834081 |
| 67 | Optic disc pallor (HP:0000543) | 2.21550056 |
| 68 | Increased cerebral lipofuscin (HP:0011813) | 2.20538024 |
| 69 | Vaginal atresia (HP:0000148) | 2.20481345 |
| 70 | Axonal loss (HP:0003447) | 2.20286226 |
| 71 | Genital tract atresia (HP:0001827) | 2.19840597 |
| 72 | Increased serum pyruvate (HP:0003542) | 2.19400322 |
| 73 | Abnormality of glycolysis (HP:0004366) | 2.19400322 |
| 74 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.19165884 |
| 75 | Prolonged neonatal jaundice (HP:0006579) | 2.18044860 |
| 76 | Depression (HP:0000716) | 2.17661455 |
| 77 | Amblyopia (HP:0000646) | 2.17517237 |
| 78 | Inability to walk (HP:0002540) | 2.16705690 |
| 79 | Postural tremor (HP:0002174) | 2.15399724 |
| 80 | Inappropriate behavior (HP:0000719) | 2.15187964 |
| 81 | Amyloidosis (HP:0011034) | 2.15060296 |
| 82 | Blue irides (HP:0000635) | 2.13779043 |
| 83 | Drooling (HP:0002307) | 2.13336120 |
| 84 | Excessive salivation (HP:0003781) | 2.13336120 |
| 85 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.13241275 |
| 86 | Oligomenorrhea (HP:0000876) | 2.12649289 |
| 87 | Agnosia (HP:0010524) | 2.11365478 |
| 88 | Metaphyseal irregularity (HP:0003025) | 2.10156319 |
| 89 | Leukodystrophy (HP:0002415) | 2.08296198 |
| 90 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.07774605 |
| 91 | Agitation (HP:0000713) | 2.07667309 |
| 92 | Delusions (HP:0000746) | 2.07148036 |
| 93 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.06645676 |
| 94 | Recurrent bacterial skin infections (HP:0005406) | 2.05659415 |
| 95 | Protruding tongue (HP:0010808) | 2.05213845 |
| 96 | Generalized myoclonic seizures (HP:0002123) | 2.02408523 |
| 97 | Dysmetria (HP:0001310) | 2.01077342 |
| 98 | Abnormality of glycolipid metabolism (HP:0010969) | 1.99907426 |
| 99 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.99907426 |
| 100 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.99907426 |
| 101 | Neuronal loss in central nervous system (HP:0002529) | 1.99438007 |
| 102 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.99119105 |
| 103 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.99119105 |
| 104 | Retinal dysplasia (HP:0007973) | 1.98872755 |
| 105 | Psychosis (HP:0000709) | 1.98809304 |
| 106 | Bone cyst (HP:0012062) | 1.98567362 |
| 107 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.98229509 |
| 108 | Muscle fibrillation (HP:0010546) | 1.97912766 |
| 109 | Recurrent abscess formation (HP:0002722) | 1.97879164 |
| 110 | Dysostosis multiplex (HP:0000943) | 1.97237869 |
| 111 | Tetraparesis (HP:0002273) | 1.94859265 |
| 112 | Mutism (HP:0002300) | 1.94778035 |
| 113 | Retinal atrophy (HP:0001105) | 1.93591965 |
| 114 | Zonular cataract (HP:0010920) | 1.93492917 |
| 115 | Poor eye contact (HP:0000817) | 1.93375300 |
| 116 | Esotropia (HP:0000565) | 1.92288175 |
| 117 | Cardiomegaly (HP:0001640) | 1.90983973 |
| 118 | Eczematoid dermatitis (HP:0000976) | 1.90809288 |
| 119 | Episodic fever (HP:0001954) | 1.90189562 |
| 120 | Specific learning disability (HP:0001328) | 1.89825368 |
| 121 | Petechiae (HP:0000967) | 1.89705725 |
| 122 | Hepatic necrosis (HP:0002605) | 1.89536919 |
| 123 | Myoclonus (HP:0001336) | 1.87870690 |
| 124 | Clumsiness (HP:0002312) | 1.87002049 |
| 125 | Action tremor (HP:0002345) | 1.86954998 |
| 126 | Ankle clonus (HP:0011448) | 1.86730596 |
| 127 | Dementia (HP:0000726) | 1.86438267 |
| 128 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.86260499 |
| 129 | Mitral stenosis (HP:0001718) | 1.86023594 |
| 130 | Respiratory failure (HP:0002878) | 1.85574598 |
| 131 | Cortical visual impairment (HP:0100704) | 1.84346741 |
| 132 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.84117009 |
| 133 | Absent speech (HP:0001344) | 1.83186160 |
| 134 | Congenital sensorineural hearing impairment (HP:0008527) | 1.83185351 |
| 135 | Poor coordination (HP:0002370) | 1.82890104 |
| 136 | Hepatosplenomegaly (HP:0001433) | 1.82569119 |
| 137 | Abnormality of the basal ganglia (HP:0002134) | 1.81954219 |
| 138 | Hypokinesia (HP:0002375) | 1.81839278 |
| 139 | Hemiparesis (HP:0001269) | 1.81441024 |
| 140 | Dysautonomia (HP:0002459) | 1.81154022 |
| 141 | Diminished movement (HP:0002374) | 1.81070727 |
| 142 | Symptomatic seizures (HP:0011145) | 1.80774432 |
| 143 | Global brain atrophy (HP:0002283) | 1.80520489 |
| 144 | X-linked dominant inheritance (HP:0001423) | 1.80253201 |
| 145 | Basal ganglia calcification (HP:0002135) | 1.79306932 |
| 146 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.79085919 |
| 147 | J-shaped sella turcica (HP:0002680) | 1.78825112 |
| 148 | Dysdiadochokinesis (HP:0002075) | 1.78335800 |
| 149 | Cerebral hemorrhage (HP:0001342) | 1.77951680 |
| 150 | Spastic gait (HP:0002064) | 1.75953059 |
| 151 | Fetal akinesia sequence (HP:0001989) | 1.75667231 |
| 152 | Muscular hypotonia of the trunk (HP:0008936) | 1.74976921 |
| 153 | Hypoglycemic coma (HP:0001325) | 1.73139189 |
| 154 | Sensorimotor neuropathy (HP:0007141) | 1.72160334 |
| 155 | Hypoglycemic seizures (HP:0002173) | 1.70690764 |
| 156 | Tetany (HP:0001281) | 1.70497892 |
| 157 | Glomerulonephritis (HP:0000099) | 1.69662774 |
| 158 | Protuberant abdomen (HP:0001538) | 1.68715473 |
| 159 | Purpura (HP:0000979) | 1.67283907 |
| 160 | Xanthomatosis (HP:0000991) | 1.67202326 |
| 161 | Albinism (HP:0001022) | 1.62652725 |
| 162 | Myocardial infarction (HP:0001658) | 1.62645636 |
| 163 | Abnormal neuron morphology (HP:0012757) | 1.62606974 |
| 164 | Abnormality of the motor neurons (HP:0002450) | 1.62606974 |
| 165 | Memory impairment (HP:0002354) | 1.61674684 |
| 166 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.61323922 |
| 167 | Ketoacidosis (HP:0001993) | 1.58593854 |
| 168 | Poor head control (HP:0002421) | 1.54347158 |
| 169 | Delayed gross motor development (HP:0002194) | 1.54122519 |
| 170 | Hyperglycemia (HP:0003074) | 1.51707331 |
| 171 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.51630650 |
| 172 | Abnormality of the anterior horn cell (HP:0006802) | 1.50365633 |
| 173 | Degeneration of anterior horn cells (HP:0002398) | 1.50365633 |
| 174 | Restlessness (HP:0000711) | 1.49043145 |
| 175 | Focal dystonia (HP:0004373) | 1.47965127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.87304336 |
| 2 | MAP3K12 | 3.84653046 |
| 3 | NTRK3 | 3.29758962 |
| 4 | MAP2K7 | 3.13531937 |
| 5 | MAP3K4 | 2.75673390 |
| 6 | RIPK4 | 2.64031103 |
| 7 | TESK1 | 2.63362098 |
| 8 | MAP4K2 | 2.59047795 |
| 9 | CDK19 | 2.40283443 |
| 10 | PLK2 | 2.26998070 |
| 11 | EPHA4 | 2.26921679 |
| 12 | ARAF | 2.15309446 |
| 13 | OXSR1 | 2.14811986 |
| 14 | MAP3K9 | 2.06931351 |
| 15 | GRK5 | 2.01901651 |
| 16 | AKT3 | 1.85556987 |
| 17 | MINK1 | 1.80648845 |
| 18 | NME1 | 1.73086361 |
| 19 | ACVR1B | 1.72656295 |
| 20 | TRIM28 | 1.70005697 |
| 21 | DAPK1 | 1.67784814 |
| 22 | MAP2K4 | 1.64859274 |
| 23 | DAPK2 | 1.62262511 |
| 24 | TSSK6 | 1.59640286 |
| 25 | BMPR2 | 1.58853300 |
| 26 | NTRK1 | 1.57551242 |
| 27 | CSNK1G1 | 1.57524417 |
| 28 | CAMKK2 | 1.57052951 |
| 29 | MARK1 | 1.54781024 |
| 30 | TGFBR2 | 1.51894882 |
| 31 | EPHA3 | 1.44238509 |
| 32 | BMPR1B | 1.43237732 |
| 33 | DDR2 | 1.40630226 |
| 34 | INSRR | 1.39880615 |
| 35 | PNCK | 1.34113397 |
| 36 | GRK7 | 1.33677684 |
| 37 | CSNK1A1L | 1.31515701 |
| 38 | MAP3K3 | 1.31272286 |
| 39 | CCNB1 | 1.28826319 |
| 40 | PINK1 | 1.27865203 |
| 41 | PRPF4B | 1.25222112 |
| 42 | TNIK | 1.24695447 |
| 43 | NTRK2 | 1.21107495 |
| 44 | TYK2 | 1.20545831 |
| 45 | CAMK2B | 1.19072623 |
| 46 | CAMK2A | 1.17233484 |
| 47 | MAP3K14 | 1.16369794 |
| 48 | ABL2 | 1.15925076 |
| 49 | CDK5 | 1.15474565 |
| 50 | BRAF | 1.14833339 |
| 51 | PRKCG | 1.12721600 |
| 52 | BCR | 1.09466889 |
| 53 | STK39 | 1.09433523 |
| 54 | JAK1 | 1.07718032 |
| 55 | PRKCE | 1.06763569 |
| 56 | SIK3 | 1.05191364 |
| 57 | MAP3K2 | 1.05070399 |
| 58 | FES | 1.02997064 |
| 59 | ADRBK2 | 1.02426846 |
| 60 | MAPK13 | 1.01207723 |
| 61 | BLK | 0.97164820 |
| 62 | UHMK1 | 0.94478564 |
| 63 | TBK1 | 0.92103500 |
| 64 | GRK1 | 0.92053946 |
| 65 | IRAK3 | 0.90570525 |
| 66 | FGR | 0.88873052 |
| 67 | PIM2 | 0.88736274 |
| 68 | WNK4 | 0.88165630 |
| 69 | MAPKAPK5 | 0.87937999 |
| 70 | TAOK3 | 0.87826563 |
| 71 | SGK223 | 0.87637530 |
| 72 | SGK494 | 0.87637530 |
| 73 | PHKG1 | 0.87147238 |
| 74 | PHKG2 | 0.87147238 |
| 75 | CAMK2D | 0.86426861 |
| 76 | STK16 | 0.82217448 |
| 77 | MST4 | 0.81282104 |
| 78 | KSR2 | 0.80689457 |
| 79 | PTK2B | 0.79966138 |
| 80 | CSNK1G2 | 0.76790020 |
| 81 | ADRBK1 | 0.76205965 |
| 82 | MATK | 0.75532765 |
| 83 | MAP2K6 | 0.75019942 |
| 84 | MOS | 0.74947843 |
| 85 | NEK9 | 0.73283268 |
| 86 | CDK14 | 0.72075921 |
| 87 | PDK4 | 0.72075839 |
| 88 | PDK3 | 0.72075839 |
| 89 | MAP3K13 | 0.71129200 |
| 90 | IKBKB | 0.70819928 |
| 91 | WNK3 | 0.69820796 |
| 92 | CDK18 | 0.69135509 |
| 93 | PDK2 | 0.67958015 |
| 94 | RPS6KA4 | 0.66947195 |
| 95 | PAK6 | 0.66161392 |
| 96 | MAP3K5 | 0.65145724 |
| 97 | CAMK2G | 0.65055032 |
| 98 | MYLK | 0.64855110 |
| 99 | CDK8 | 0.63980643 |
| 100 | CDK15 | 0.62734888 |
| 101 | EPHB1 | 0.61548011 |
| 102 | CSF1R | 0.61280195 |
| 103 | GSK3A | 0.60513063 |
| 104 | SGK2 | 0.59623052 |
| 105 | MAPK15 | 0.58940278 |
| 106 | BCKDK | 0.58441373 |
| 107 | DYRK1A | 0.58436129 |
| 108 | MAP3K1 | 0.57633275 |
| 109 | SCYL2 | 0.57632559 |
| 110 | FGFR2 | 0.57578678 |
| 111 | CAMKK1 | 0.57544291 |
| 112 | CSNK1G3 | 0.57533808 |
| 113 | MAP3K11 | 0.54869060 |
| 114 | TESK2 | 0.54472940 |
| 115 | MUSK | 0.52846012 |
| 116 | TXK | 0.50573464 |
| 117 | CDK11A | 0.50466997 |
| 118 | KSR1 | 0.48606264 |
| 119 | FGFR3 | 0.48426776 |
| 120 | TAOK1 | 0.48366895 |
| 121 | ABL1 | 0.48237445 |
| 122 | STK38L | 0.47281833 |
| 123 | ROCK2 | 0.45673623 |
| 124 | FER | 0.45253418 |
| 125 | JAK2 | 0.44840603 |
| 126 | LIMK1 | 0.44153622 |
| 127 | CSK | 0.43973502 |
| 128 | PAK4 | 0.43933762 |
| 129 | DAPK3 | 0.43723002 |
| 130 | EIF2AK3 | 0.43550604 |
| 131 | IRAK2 | 0.43080260 |
| 132 | NLK | 0.42518136 |
| 133 | LYN | 0.41385414 |
| 134 | FRK | 0.41171648 |
| 135 | PRKCH | 0.40513804 |
| 136 | SGK1 | 0.40402271 |
| 137 | PRKACA | 0.39940711 |
| 138 | NEK6 | 0.38701752 |
| 139 | PDPK1 | 0.38111496 |
| 140 | YES1 | 0.37474106 |
| 141 | SIK2 | 0.36965346 |
| 142 | ERBB4 | 0.36169542 |
| 143 | PAK3 | 0.36013238 |
| 144 | ERBB3 | 0.35560023 |
| 145 | CSNK1A1 | 0.35328882 |
| 146 | MAP2K1 | 0.34344940 |
| 147 | PRKCA | 0.33888739 |
| 148 | RET | 0.33521988 |
| 149 | GRK6 | 0.33272365 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 4.20108230 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.06689936 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.50257627 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.18325267 |
| 5 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 3.05141095 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.50224387 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.43794121 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.21014031 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.16415679 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.07408379 |
| 11 | Taste transduction_Homo sapiens_hsa04742 | 2.01816579 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 1.98142884 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 1.97010829 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.94423411 |
| 15 | Protein export_Homo sapiens_hsa03060 | 1.92494951 |
| 16 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.89476437 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.88559409 |
| 18 | Olfactory transduction_Homo sapiens_hsa04740 | 1.86828493 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.85826758 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.82281187 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.81347460 |
| 22 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.77757314 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.55405210 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.51030300 |
| 25 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.49002256 |
| 26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.45888634 |
| 27 | Salivary secretion_Homo sapiens_hsa04970 | 1.44553456 |
| 28 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.44447652 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.43702198 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.41213926 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.40873674 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.38075107 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.35199587 |
| 34 | Huntingtons disease_Homo sapiens_hsa05016 | 1.34710307 |
| 35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.34019721 |
| 36 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.31515250 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.28735785 |
| 38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.27525090 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.24831934 |
| 40 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.24518042 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.21767574 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 1.17677063 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.17138761 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15519415 |
| 45 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.15229551 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.14264603 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.12089550 |
| 48 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.09749637 |
| 49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.07209502 |
| 50 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.06619930 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 1.06150972 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.05331140 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02139269 |
| 54 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.96705314 |
| 55 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90520883 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89518393 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.88250757 |
| 58 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.84666504 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84401542 |
| 60 | Phototransduction_Homo sapiens_hsa04744 | 0.83635823 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83397604 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81548594 |
| 63 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.78379669 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.78028385 |
| 65 | Malaria_Homo sapiens_hsa05144 | 0.77170405 |
| 66 | Gap junction_Homo sapiens_hsa04540 | 0.76998098 |
| 67 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76717442 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71231153 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69927480 |
| 70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.69905624 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 0.68887590 |
| 72 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68685505 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67682496 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66505908 |
| 75 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66252461 |
| 76 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.65833936 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65545566 |
| 78 | Asthma_Homo sapiens_hsa05310 | 0.65510040 |
| 79 | Shigellosis_Homo sapiens_hsa05131 | 0.65304546 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.64083142 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.62651060 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62560522 |
| 83 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61384793 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60969014 |
| 85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60814099 |
| 86 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60594163 |
| 87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60311348 |
| 88 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.58089507 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.55930580 |
| 90 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.54682941 |
| 91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54510692 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53108828 |
| 93 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51668287 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50916460 |
| 95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.50398845 |
| 96 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.49695129 |
| 97 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48654931 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48603776 |
| 99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48558530 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48102739 |
| 101 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47221177 |
| 102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47174600 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45143803 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43597680 |
| 105 | Amoebiasis_Homo sapiens_hsa05146 | 0.43117403 |
| 106 | Proteasome_Homo sapiens_hsa03050 | 0.42783556 |
| 107 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.42374419 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42268376 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40334640 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39833249 |
| 111 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.39577229 |
| 112 | Alcoholism_Homo sapiens_hsa05034 | 0.39549409 |
| 113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.38992077 |
| 114 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.38875195 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37849241 |
| 116 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.37588546 |
| 117 | Axon guidance_Homo sapiens_hsa04360 | 0.37548399 |
| 118 | Allograft rejection_Homo sapiens_hsa05330 | 0.37392947 |
| 119 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.36864732 |
| 120 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.35815629 |
| 121 | Melanogenesis_Homo sapiens_hsa04916 | 0.35486307 |
| 122 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.34721807 |
| 123 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.34430641 |
| 124 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32881363 |
| 125 | Tuberculosis_Homo sapiens_hsa05152 | 0.32758555 |
| 126 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.32607477 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32173670 |
| 128 | Circadian rhythm_Homo sapiens_hsa04710 | 0.30606384 |
| 129 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.30149855 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.29478803 |
| 131 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28333211 |
| 132 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27975179 |
| 133 | Mineral absorption_Homo sapiens_hsa04978 | 0.27956602 |
| 134 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.27050640 |
| 135 | Glioma_Homo sapiens_hsa05214 | 0.26353719 |
| 136 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.25371321 |
| 137 | Endocytosis_Homo sapiens_hsa04144 | 0.22798220 |
| 138 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.19251724 |
| 139 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17884997 |
| 140 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.15400989 |

